Updates on the management of inflammatory bowel disease from periconception to pregnancy and lactation

Thiopurine Metabolite Shunting in Late Pregnancy Increases the Risk of Intrahepatic Cholestasis of Pregnancy in Women With Inflammatory Bowel Disease, and Can be Managed With Split Dosing

Safety of vedolizumab and ustekinumab compared with anti-TNF in pregnant women with inflammatory bowel disease

Pregnancy Outcomes in the Ozanimod Clinical Development Program in Patients With Ulcerative Colitis, Crohn’s Disease, and Relapsing Multiple Sclerosis

Tofacitinib concentrations in plasma and breastmilk of a lactating woman with ulcerative colitis

Inflammatory bowel disease can reduce ovarian reserve function in women: A systematic review and meta-analysis

Maternal and Neonatal Outcomes in Vedolizumab and Ustekinumab Exposed Pregnancies: Results from the PIANO registry

Immunological effects and safety of live rotavirus vaccination after antenatal exposure to immunomodulatory biologic agents: a prospective cohort study from the Canadian Immunization Research Network

European Crohn’s and Colitis Guidelines on Sexuality, Fertility, Pregnancy, and Lactation

Pregnancy outcomes following periconceptional or gestational exposure to ustekinumab: Review of cases reported to the manufacturer’s global safety database